| scholarly article | Q13442814 |
| P5530 | Altmetric DOI | 10.1038/SJ.BJC.6600886 |
| P6409 | CORE ID | 42000927 |
| P6179 | Dimensions Publication ID | 1022503669 |
| P356 | DOI | 10.1038/SJ.BJC.6600886 |
| P953 | full work available at URL | http://eprints.whiterose.ac.uk/99128/ |
| P932 | PMC publication ID | 2747576 |
| P698 | PubMed publication ID | 12698183 |
| P5875 | ResearchGate publication ID | 10802595 |
| P50 | author | Keith R. Abrams | Q51913713 |
| Paul C Lambert | Q61651624 | ||
| P2093 | author name string | D R Jones | |
| S A Burchill | |||
| A J Sutton | |||
| D Heney | |||
| R D Riley | |||
| P2860 | cites work | Review of survival analyses published in cancer journals | Q36081455 |
| Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG) | Q36619429 | ||
| Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group | Q36790212 | ||
| Dangers of using "optimal" cutpoints in the evaluation of prognostic factors | Q40752297 | ||
| The United Kingdom Children's Cancer Study Group--the first 20 years of growth and development. | Q41616692 | ||
| Effects of adjusting for censoring on meta-analyses of time-to-event outcomes. | Q43533201 | ||
| Standards, options and recommendations for tumor markers in colorectal cancer | Q43855584 | ||
| Does age influence the behaviour of localized prostate cancer? | Q44199125 | ||
| Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique. | Q52864122 | ||
| Systematic Reviews in Health Care | Q56528741 | ||
| Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study | Q57262599 | ||
| Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma. Findings from three independent clinical trials. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer | Q71089023 | ||
| The current contribution of molecular factors to risk estimation in neuroblastoma patients | Q74360661 | ||
| Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients | Q77493218 | ||
| [Unresected colorectal liver metastases: prognostic value of laboratory variables] | Q77639896 | ||
| Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 | ||
| Publishing raw data and real time statistical analysis on e-journals | Q30635977 | ||
| Individual patient-versus literature-based meta-analysis of survival data: time to event and event rate at a particular time can make a difference, an example based on head and neck cancer. | Q30661552 | ||
| A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis | Q30669346 | ||
| Methodological challenges in the evaluation of prognostic factors in breast cancer | Q33538459 | ||
| Traditional reviews, meta-analyses and pooled analyses in epidemiology | Q33589615 | ||
| Meta-analysis of the literature or of individual patient data: is there a difference? | Q34334544 | ||
| Systematic review of prediction of poor outcome in anoxic-ischaemic coma with biochemical markers of brain damage | Q34422393 | ||
| A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family. | Q35035224 | ||
| A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma | Q35084191 | ||
| Oral contraceptive use and breast cancer risk: a meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use | Q35878942 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | future | Q344 |
| P304 | page(s) | 1191-1198 | |
| P577 | publication date | 2003-04-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future | |
| P478 | volume | 88 |
| Q55658806 | A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma. |
| Q37689359 | A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck |
| Q81367068 | Biologic staging of non-small-cell lung cancer: prospect or proposal? |
| Q54982565 | Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. |
| Q35999015 | Chapter 12: systematic review of prognostic tests |
| Q38671095 | Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles |
| Q56880302 | EQUATOR: reporting guidelines for health research |
| Q34955266 | EQUATOR: reporting guidelines for health research. |
| Q36518927 | Early childhood assessments of community pediatric professionals predict autism spectrum and attention deficit hyperactivity problems |
| Q28751824 | Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease |
| Q54346421 | Evaluation of predictive capacities of biomarkers based on research synthesis. |
| Q34055535 | Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations. |
| Q44246219 | Gauze padding: a simple technique to delineate small oral cavity tumors |
| Q21563406 | Guidelines for reporting health research: the EQUATOR network's survey of guideline authors |
| Q52979961 | Identification of clinically useful cancer prognostic factors: what are we missing? |
| Q37419161 | Immunohistochemical prognostic markers in intracranial ependymomas: systematic review and meta-analysis |
| Q21559668 | Individual participant data meta-analysis for a binary outcome: one-stage or two-stage? |
| Q34244162 | Individual participant data meta-analysis of prognostic factor studies: state of the art? |
| Q34207372 | Individual patient data meta-analysis of survival data using Poisson regression models |
| Q37965397 | Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype |
| Q36147848 | MALDI-MS-Based Profiling of Serum Proteome: Detection of Changes Related to Progression of Cancer and Response to Anticancer Treatment. |
| Q40000127 | Meta-analysis of prognostic studies for a biomarker with a study-specific cutoff value. |
| Q24810271 | Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt |
| Q31113128 | Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data |
| Q36731636 | Minimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: A Clinical Evidence Review |
| Q30937722 | Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines |
| Q37974614 | Molecular classification of breast carcinomas with particular emphasis on "basal-like" carcinoma: a critical review |
| Q37152636 | Multivariate meta-analysis of prognostic factor studies with multiple cut-points and/or methods of measurement |
| Q26775003 | Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling |
| Q50562055 | Outcomes and recurrence patterns according to breast cancer subtypes in Korean women. |
| Q30599542 | Overview of data-synthesis in systematic reviews of studies on outcome prediction models. |
| Q36019346 | P53 abnormalities and outcomes in colorectal cancer: a systematic review. |
| Q81525370 | Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers |
| Q34790468 | Pre-arrest predictors of survival after resuscitation from out-of-hospital cardiac arrest in the elderly a systematic review |
| Q36304030 | Primer: an evidence-based approach to prognostic markers |
| Q28709212 | Prognosis Research Strategy (PROGRESS) 2: prognostic factor research |
| Q58215238 | Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens |
| Q37635115 | Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores. |
| Q28388487 | Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond |
| Q38052940 | Prognostic research and its potential role in modern gynaecology: a call for more prognostic research in urogynaecology |
| Q38187451 | Prognostic value of circulating cytokines on overall survival and disease-free survival in cancer patients |
| Q36693620 | Protocol for a systematic review of the diagnostic and prognostic utility of tests currently available for the detection of aspirin resistance in patients with established cardiovascular or cerebrovascular disease |
| Q44579323 | REporting recommendations for tumor MARKer prognostic studies (REMARK). |
| Q36615178 | REporting recommendations for tumour MARKer prognostic studies (REMARK) |
| Q30514241 | Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration |
| Q37481046 | Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines |
| Q93013744 | Reporting quality of the 2014 Ebola outbreak in Africa: A systematic analysis |
| Q59822429 | Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration |
| Q35010662 | Role of AFP mRNA expression in peripheral blood as a predictor for postsurgical recurrence of hepatocellular carcinoma: a systematic review and meta-analysis |
| Q24289520 | STRengthening analytical thinking for observational studies: the STRATOS initiative |
| Q27826357 | Sharing Detailed Research Data Is Associated with Increased Citation Rate |
| Q57800655 | Strength in Numbers: The WWARN Case Study of Purpose-Driven Data Sharing |
| Q37771732 | Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people |
| Q33938797 | The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV. |
| Q53064016 | Time-dependent summary receiver operating characteristics for meta-analysis of prognostic studies. |
| Q57556407 | Use of genome-wide high-throughput technologies in biomarker development |
| Q82494891 | [Diagnostic (STARD) and prognostic (REMARK) studies] |
Search more.